Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
Journal of Cancer Research and Clinical Oncology|April 2, 2017
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysisFrancis J Giles, Delphine Rea, Gianantonio Rosti, et al.
The New England Journal of Medicine|September 25, 2009
High-dose daunorubicin in older patients with acute myeloid leukemiaBob Löwenberg, Gert J Ossenkoppele, Wim van Putten, et al.
Cytometry. Part B, Clinical Cytometry|August 23, 2024
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cellsTom Reuvekamp, Luca L G Janssen, Lok Lam Ngai, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Blood|January 28, 2010
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 studyBob Löwenberg, Joachim Beck, Carlos Graux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapyPau Montesinos, José D González, José González, et al.
Blood|October 14, 2016
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based nichesAntonella Antonelli, Willy A Noort, Jenny Jaques, et al.
Blood|January 12, 2019
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patientsGerwin Huls, Dana A Chitu, Violaine Havelange, et al.
Cancer Research|November 19, 2004
C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemiaAlexander B H Bakker, Sonja van den Oudenrijn, Arjen Q Bakker, et al.
Blood|October 24, 2002
High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patientsSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Claudia Erpelinck, Wim L J van Putten, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Journal of Cancer Research and Clinical Oncology|April 2, 2017
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysisFrancis J Giles, Delphine Rea, Gianantonio Rosti, et al.
The New England Journal of Medicine|September 25, 2009
High-dose daunorubicin in older patients with acute myeloid leukemiaBob Löwenberg, Gert J Ossenkoppele, Wim van Putten, et al.
Cytometry. Part B, Clinical Cytometry|August 23, 2024
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cellsTom Reuvekamp, Luca L G Janssen, Lok Lam Ngai, et al.
Haematologica|December 21, 2014
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemiaEolia Brissot, Myriam Labopin, Marielle M Beckers, et al.
Blood|January 28, 2010
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 studyBob Löwenberg, Joachim Beck, Carlos Graux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapyPau Montesinos, José D González, José González, et al.
Blood|October 14, 2016
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based nichesAntonella Antonelli, Willy A Noort, Jenny Jaques, et al.
Blood|January 12, 2019
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patientsGerwin Huls, Dana A Chitu, Violaine Havelange, et al.
Cancer Research|November 19, 2004
C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemiaAlexander B H Bakker, Sonja van den Oudenrijn, Arjen Q Bakker, et al.
Blood|October 24, 2002
High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patientsSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Claudia Erpelinck, Wim L J van Putten, et al.
Pageof 20